Coyote Ventures

Coyote Ventures is an early-stage venture firm with a clear focus on women’s health and femtech, investing in companies advancing women’s wellness, reproductive health, maternal health, sexual wellness, and adjacent female-centric care categories. The firm has built a thesis-driven portfolio in a category that has been historically underfunded, with a particular willingness to back female-founded companies and to engage at pre-seed and seed stages. For healthcare AI founders, Coyote is a strong fit if you are building AI applications in fertility, menstrual and hormonal health, perimenopause and menopause, maternal monitoring, gynecologic diagnostics, sexual health, or any women’s health vertical where AI is a meaningful enabler of clinical or consumer outcomes. Check sizes typically run $100K to $500K at pre-seed and seed, often as a co-investor rather than lead, with the firm bringing meaningful network value in the femtech ecosystem and ability to signal to other thesis-aligned investors. Founders building healthcare AI outside the women’s health vertical, for example, oncology platforms, hospital workflow AI, or general-population digital therapeutics, should not approach Coyote, as the thesis is sharply scoped and a non-fit pitch will not convert. Entry path is LinkedIn outreach to the founding team, the website contact form, or referral through a femtech founder in the portfolio. Founders should come prepared to discuss specific clinical or consumer outcomes, defensible data or model advantages in their women’s health vertical, and a credible go-to-market path through providers, employers, or direct-to-consumer channels.